AI in Clinical and Molecular Diagnostics Market

Report Highlights

The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.

Report Includes

• 27 data tables and 41 additional tables
• An analysis of the current and future global markets for AI in clinical and molecular diagnostics
• Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
• Estimates of the market size and revenue forecasts for the global market for AI in clinical and molecular diagnostics, with market share analysis by type of services, devices, and region
• Discussion of the rising prevalence of chronic diseases, and technological advances in biomarker discovery, disease progression prediction, and personalized treatment strategies
• Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
• Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG scores, and consumer attitudes
• Competitive intelligence, including companies’ market shares, recent M&A activity and venture funding
• Profiles of the leading companies, including Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Fujifilm Holdings Corp., and Merative

Report Scope

This report on the global market for AI in clinical and molecular diagnostics entails a comprehensive analysis of the market size, growth trends and segmentation by technology and application. It examines drivers, challenges and opportunities influencing the adoption of AI technologies in clinical and molecular diagnostics, focusing on specific applications in imaging, genomics and laboratory diagnostics. The report provides perspectives on the competitive environment, featuring profiles of leading companies and their strategic initiatives, as well as regional analyses that address the specific market dynamics in North America, Europe, Asia-Pacific, and the Rest of the World (RoW), which in this report includes Latin America and the Middle East and Africa. It also identifies emerging trends, such as the integration of AI in personalized medicine and telehealth. This report is an essential reference for stakeholders, including healthcare providers, technology developers and policymakers, seeking to navigate and capitalize on the evolving AI landscape in diagnostics.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.